Advertisement

Topics

2018 NAT and Immunohematology Market: Supplier Sales and Shares by Country, Innovative Technologies and Market Applications [Report Updated: 01011970] Prices from USD $2850

23:14 EDT 4 Oct 2018 | BioPortfolio Reports

The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.

Contains 197 pages and 6 tables

Original Article: 2018 NAT and Immunohematology Market: Supplier Sales and Shares by Country, Innovative Technologies and Market Applications [Report Updated: 01011970] Prices from USD $2850

NEXT ARTICLE

More From BioPortfolio on "2018 NAT and Immunohematology Market: Supplier Sales and Shares by Country, Innovative Technologies and Market Applications [Report Updated: 01011970] Prices from USD $2850"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...